Captrust Financial Advisors Vericel Corp Transaction History
Captrust Financial Advisors
- $33 Billion
- Q3 2024
A detailed history of Captrust Financial Advisors transactions in Vericel Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 5,912 shares of VCEL stock, worth $326,933. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,912
Previous 5,942
0.5%
Holding current value
$326,933
Previous $272,000
8.46%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VCEL
# of Institutions
276Shares Held
48.5MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$446 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$212 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$193 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$134 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$131 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.61B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...